Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects - NCT05517486

Cmax between 0 hour to 240 hour after study drug administration, Tmax between 0 hour to 240 hour after study drug administration, AUC last, AUC inf